Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5. Eur J Cancer. 2017;77:140-52. [Šekerija M]
Autori: Dal Maso L,
Tavilla A,
Pacini F,
Serraino D,
van Dijk BAC,
Chirlaque MD,
Capocaccia R,
Larranaga N,
Colonna M,
Agius D,
Ardanaz E,
Rubió-Casadevall J,
Kowalska A,
Virdone S,
Mallone S,
Amash H,
De Angelis R,
EUROCARE-5 Working GroupGodina: 2017
Erratum to “Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 396-404]. Gynecol Oncol. 2017;147(3):725. [Šekerija M]
Autori: Matz M,
Coleman MP,
Carreira H,
Salmeron D,
Chirlaque MD,
Allemani C,
CONCORD Working GroupGodina: 2017
Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2). Gynecol Oncol. 2017;144(2):396-404. [Šekerija M]
Autori: Matz M,
Coleman MP,
Carreira H,
Salmeron D,
Chirlaque MD,
Allemani C,
CONCORD Working GroupGodina: 2017
Erratum to “The histology of ovarian cancer: Worldwide distribution and implications for international survival comparisons (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 405-413]. Gynecol Oncol. 2017;147(3):726. [Šekerija M]
Autori: Matz M,
Coleman MP,
Sant M,
Chirlaque MD,
Visser O,
Gore M,
Allemani C,
the CONCORD Working GroupGodina: 2017
The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2). Gynecol Oncol. 2017;144(2):405-13. [Šekerija M]
Autori: Matz M,
Coleman MP,
Sant M,
Chirlaque MD,
Visser O,
Gore M,
Allemani C,
the CONCORD Working GroupGodina: 2017
